酶敏感的氨酸-葡萄糖水凝支持MSC的生存,并在缺乏葡萄糖的情况下保持膜功能
Paula Gonzalez-Fernandez1, Luca Simula1, Sébastien Jenni1
1School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland.
在一个新的HA-GLC水凝中,介质干细胞 (MSC) 促进骨关节炎的软骨再生. 这项技术通过提供葡萄糖来增强MSC功能,改善淋巴细胞增殖和减少炎症.
科学领域:
- 再生医学是一种再生医学.
- 生物材料科学 生物材料科学
- 细胞生物学 细胞生物学
背景情况:
- 介质细胞干细胞 (MSC) 疗法对通过膜信号传递来治疗骨关节炎 (OA) 是有前途的.
- 由于营养缺乏,无血管关节环境限制了MSC的存活率和治疗疗效.
- 开发了一种新型的酸和葡萄糖 (HA-GLC) 水凝,用于在低葡萄糖条件下维持MSC.
研究的目的:
- 研究HA-GLC水凝对MSC存活率和分泌物的影响.
- 评估葡萄糖的可用性如何影响MSC分泌体的组成和功能.
- 评估HA-GLC水凝培养的MSC分泌体在人体红细胞上的治疗潜力.
主要方法:
- 在HA-GLC水凝中加入MSC.
- 在不同的葡萄糖条件下,MSC分泌物的蛋白质组分析.
- 评估人体冠状细胞 (hCH) 增殖和IL-6分泌,以应对MSC的分泌.
主要成果:
- 在低葡萄糖环境中,HA-GLC水凝支持MSC的生存和繁殖.
- 缺乏葡萄糖会改变MSC分泌体,影响细胞外基质生产途径.
- 从提供葡萄糖的条件中分泌的MSC增强了hCH的扩散,并显著降低了IL-6的表达.
结论:
- 通过控制葡萄糖的可用性,HA-GLC水凝有效调节MSC分泌体功能.
- 这项技术显示了通过优化MSC膜活动来增强OA中的软骨再生的潜力.
- 通过HA-GLC水凝提供有针对性的葡萄糖是MSC治疗的有前途的策略.
更多相关视频
08:56Oxygen-Glucose Deprivation and Reoxygenation as an In Vitro Ischemia-Reperfusion Injury Model for Studying Blood-Brain Barrier Dysfunction
Published on: May 7, 2015
09:19Intramyocardial Transplantation of MSC-Loading Injectable Hydrogels after Myocardial Infarction in a Murine Model
Published on: September 20, 2020
相关概念视频
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Glucose Absorption Into the Small Intestine
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Paracrine Signaling
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
